Literature DB >> 25656882

PD-1 inhibitors effective in hodgkin lymphoma.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25656882     DOI： 10.1158/2159-8290.CD-NB2015-002

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  2 in total

1.  Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Authors:  Luya Cai; Xuedan Du; Cheng Zhang; Shanshan Yu; Lixiao Liu; Jinduo Zhao; Ye Zhao; Chunhong Zhang; Jinting Wu; Bin Wang; Yingyu Chen; Xiaoping Su; Xiaojian Yan; Wenfeng Li
Journal:  Cancer Immunol Immunother       Date:  2021-11-03       Impact factor: 6.630

2.  The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.

Authors:  Wu Zhuang; Junxun Ma; Xudong Chen; Guoqiang Wang; Jing Lu; Yanan Chen; Hua Dong; Shangli Cai; Yuzi Zhang; Xiaochen Zhao; Youcai Zhu; Chunwei Xu; Yunjian Huang; Zhangzhou Huang; Xiaofeng Zhu; Hong Jiang; Zhijie Wang
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.